Literature DB >> 16820345

Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.

Geru Wu1, Hongyan Tian, Ke Han, Yutao Xi, Yan Yao, Aiqun Ma.   

Abstract

It has been postulated that the loss of arterial compliance may precede cardiovascular diseases, and that arterial compliance is an important parameter to consider when evaluating arterial diseases such as essential hypertension (EH) and the effects of antihypertensive treatment. In all, 133 EH patients and 147 healthy subjects were enrolled in this study. Large arterial compliance (C1) and small arterial compliance (C2) were measured by the CVProfilor DO-2020 CardioVascular Profiling System. Thirty-five patients randomly received magnesium potassium supplementation (magnesium, 70.8 mg/d; potassium, 217.2 mg/d) for four weeks, and 32 patients received lacidipin (4 mg/d) as a control. Before and after the four weeks, blood pressure, C1, and C2 were measured. It was found that arterial compliance was significantly lower in EH patients compared with healthy subjects (C1: 12.53 +/- 0.33 vs. 15.63 +/- 0.30 ml/mmHg x 10, p < 0.01;C2: 3.79 +/- 0.17 vs. 5.69 +/- 0.25 ml/mmHg x 100, p < 0.01). On lacidipine, systolic and diastolic BP decreased 13.27 +/- 1.76 mm Hg and 6.33 +/- 1.55 mm Hg, and C1 and C2 compliance values increased 25.05% +/- 4.49% and 34.50% +/- 7.40%, respectively. On K+ and Mg2+ supplementation, systolic and diastolic BP decreased 7.83 +/- 1.87 mm Hg and 3.67 +/- 1.03 mm Hg, and C1 and C2 compliance values increased 12.44% +/- 4.43% and 45.25% +/- 6.67%, respectively. Decreases in systemic vascular resistance (mean arterial pressure divided by cardiac output) by 11.9% and 16.6 % (p < 0.01) were seen between the drug-induced changes, respectively. Both large arterial compliance and small arterial compliance were decreased in essential hypertension patients. In essential hypertension patients, magnesium and potassium supplementation could improve small arterial compliance, while lacidipine improved large arterial compliance significantly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820345     DOI: 10.1080/10641960600798705

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

Review 1.  Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence.

Authors:  Kristal J Aaron; Paul W Sanders
Journal:  Mayo Clin Proc       Date:  2013-09       Impact factor: 7.616

Review 2.  Nondrug interventions for treatment of hypertension.

Authors:  Kevin J Woolf; John D Bisognano
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-08-25       Impact factor: 3.738

3.  Blood pressure and levels of Fe, Ca, Mg, Zn, Cu, Na and K in the hair of young Bantu men from Tanzania.

Authors:  Ewa Rębacz-Maron; Irena Baranowska-Bosiacka; Izabela Gutowska; Dariusz Chlubek
Journal:  Biol Trace Elem Res       Date:  2013-01-03       Impact factor: 3.738

4.  Magnesium and vascular changes in hypertension.

Authors:  Ana Rosa Cunha; Bianca Umbelino; Margarida L Correia; Mario Fritsch Neves
Journal:  Int J Hypertens       Date:  2012-02-29       Impact factor: 2.420

5.  Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.

Authors:  Jalal Poorolajal; Fatemeh Zeraati; Ali Reza Soltanian; Vida Sheikh; Elham Hooshmand; Akram Maleki
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

6.  Dietary potassium supplementation improves vascular structure and ameliorates the damage caused by cerebral ischemia in normotensive rats.

Authors:  Christine' S Rigsby; David M Pollock; Anne M Dorrance
Journal:  Nutr Metab (Lond)       Date:  2008-01-31       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.